Epidermal growth factor receptor (EGFR) is commonly overexpressed on many types of epithelial malignancies, including lung, kidney, and colon cancers; however, it is also expressed on healthy tissue, leading to an increase in the chances for “on-target, off-tumour” effects [156]. This evidence concerns the gene EGFR and colonic neoplasm.